JP2023547770A5 - - Google Patents
Info
- Publication number
- JP2023547770A5 JP2023547770A5 JP2023518997A JP2023518997A JP2023547770A5 JP 2023547770 A5 JP2023547770 A5 JP 2023547770A5 JP 2023518997 A JP2023518997 A JP 2023518997A JP 2023518997 A JP2023518997 A JP 2023518997A JP 2023547770 A5 JP2023547770 A5 JP 2023547770A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- disease
- acceptable salt
- tautomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083685P | 2020-09-25 | 2020-09-25 | |
| US63/083,685 | 2020-09-25 | ||
| PCT/US2021/052074 WO2022067114A1 (en) | 2020-09-25 | 2021-09-24 | Compounds and compositions as modulators of tlr signaling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547770A JP2023547770A (ja) | 2023-11-14 |
| JP2023547770A5 true JP2023547770A5 (enExample) | 2024-10-22 |
Family
ID=78650032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518997A Pending JP2023547770A (ja) | 2020-09-25 | 2021-09-24 | Ｔｌｒシグナル伝達の調節剤としての化合物及び組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240043395A1 (enExample) |
| EP (1) | EP4217342A1 (enExample) |
| JP (1) | JP2023547770A (enExample) |
| KR (1) | KR20230074744A (enExample) |
| CN (1) | CN116507607A (enExample) |
| AR (1) | AR123604A1 (enExample) |
| AU (1) | AU2021347364A1 (enExample) |
| CA (1) | CA3193577A1 (enExample) |
| CL (1) | CL2023000853A1 (enExample) |
| CO (1) | CO2023005057A2 (enExample) |
| CR (1) | CR20230177A (enExample) |
| IL (1) | IL301574A (enExample) |
| MX (1) | MX2023003348A (enExample) |
| PE (1) | PE20231209A1 (enExample) |
| TW (1) | TW202229249A (enExample) |
| WO (1) | WO2022067114A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024008868A (es) | 2022-01-18 | 2024-09-23 | Maze Therapeutics Inc | Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso. |
| EP4554595A4 (en) * | 2022-07-11 | 2026-04-01 | Univ Rutgers | GALPHA12 INHIBITORS AND THEIR METHODS OF USE |
| WO2024099404A1 (zh) * | 2022-11-10 | 2024-05-16 | 北京普祺医药科技股份有限公司 | 一种含氮螺环类化合物、药物组合物以及其用途 |
| PY2404093A (es) * | 2023-01-30 | 2024-10-03 | Eurofarma Laboratorios S A | Hidrazidas bloqueadoras de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de los mismos y kits |
| CN116425698B (zh) * | 2023-06-15 | 2023-08-29 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 甲基噻唑类化合物及其制备方法和应用 |
| WO2025106383A1 (en) * | 2023-11-17 | 2025-05-22 | Merck Sharp & Dohme Llc | Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators |
| CN118994047B (zh) * | 2024-08-13 | 2026-02-10 | 中国药科大学 | 一种水杨醛衍生物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0513387T3 (da) * | 1990-11-30 | 2000-06-05 | Otsuka Pharma Co Ltd | Thiazolderivater som inhibitorer af aktivt oxygen |
| CN1761654A (zh) | 2003-03-25 | 2006-04-19 | 住友化学株式会社 | 吡唑化合物 |
| JP2006199941A (ja) * | 2004-12-20 | 2006-08-03 | Chisso Corp | クロマン環を有する化合物を含有する液晶組成物 |
| HRP20230125T1 (hr) * | 2018-03-27 | 2023-06-09 | Neuropore Therapies, Inc. | Spojevi kao modulatori signaliziranja tlr2 |
| US11299487B2 (en) * | 2019-03-26 | 2022-04-12 | Neuropore Therapies, Inc. | Compounds and compositions as modulators of TLR signaling |
-
2021
- 2021-09-24 CA CA3193577A patent/CA3193577A1/en active Pending
- 2021-09-24 IL IL301574A patent/IL301574A/en unknown
- 2021-09-24 EP EP21810154.1A patent/EP4217342A1/en active Pending
- 2021-09-24 JP JP2023518997A patent/JP2023547770A/ja active Pending
- 2021-09-24 AU AU2021347364A patent/AU2021347364A1/en active Pending
- 2021-09-24 CN CN202180065780.6A patent/CN116507607A/zh active Pending
- 2021-09-24 KR KR1020237012231A patent/KR20230074744A/ko active Pending
- 2021-09-24 WO PCT/US2021/052074 patent/WO2022067114A1/en not_active Ceased
- 2021-09-24 MX MX2023003348A patent/MX2023003348A/es unknown
- 2021-09-24 CR CR20230177A patent/CR20230177A/es unknown
- 2021-09-24 US US18/027,005 patent/US20240043395A1/en active Pending
- 2021-09-24 TW TW110135689A patent/TW202229249A/zh unknown
- 2021-09-24 AR ARP210102666A patent/AR123604A1/es unknown
- 2021-09-24 PE PE2023001210A patent/PE20231209A1/es unknown
-
2023
- 2023-03-23 CL CL2023000853A patent/CL2023000853A1/es unknown
- 2023-04-21 CO CONC2023/0005057A patent/CO2023005057A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508407A5 (enExample) | ||
| JP2024166311A (ja) | 化合物、組成物、及び、方法 | |
| JP2024086819A (ja) | 化合物、組成物、及び、方法 | |
| JP2009114202A (ja) | ホスフォノセフェム誘導体、その製造法および用途 | |
| DK161024B (da) | Analogifremgangsmaade til fremstilling af cephalosporinderivater | |
| BG60437B2 (bg) | Тиазолилацетамиди | |
| JP2022544714A5 (enExample) | ||
| JP2014523901A5 (enExample) | ||
| CH630923A5 (de) | Verfahren zur herstellung von neuen cephalosporinderivaten. | |
| JPH0314039B2 (enExample) | ||
| JP2007522142A5 (enExample) | ||
| US20240043395A1 (en) | Compounds and compositions as modulators of tlr signaling | |
| JPH0333712B2 (enExample) | ||
| DD298104A5 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| DK156900B (da) | Analogifremgangsmaade til fremstilling af cephalosporinderivater | |
| DE69028342T2 (de) | Cephalosporinverbindungen und Verfahren zu ihrer Herstellung | |
| NO793688L (no) | Fremgangsmaate ved fremstilling av cephalosporinderivater | |
| JP2025514802A5 (enExample) | ||
| DE69132580T2 (de) | 7-Acyl-3-(substituierte carbamoyloxy) Cephem Verbindungen, Verfahren zu ihrer Herstellung und Anwendung | |
| CH651574A5 (de) | Cephalosporinantibiotika, ihre herstellung und pharmazeutische zubereitungen. | |
| JPH0461000B2 (enExample) | ||
| JPS6310792A (ja) | 新規セフエム化合物 | |
| JP2024540937A (ja) | Ｌｐａ受容体活性に関連する状態を処置するための化合物および組成物 | |
| DE3784778T2 (de) | Cephemverbindungen, ihre herstellung und anwendung. | |
| DE10129716A1 (de) | Kombinationspräparate zur Herpes-Behandlung |